Altered nucleolar morphology in substantia nigra dopamine neurons following 6-hydroxydopamine lesion in rats

Neuroscience Letters

Volumn 546, Issue , 2013, Pages 26-30

  Healy Stoffel, Michelle ^a   Ahmad, S Omar ^b   Stanford, John A ^a   Levant, Beth ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

6 Hydroxydopamine; Neuronal morphology; Nucleolar volume; Silver nucleolar stain; Stereology; Substantia nigra pars compacta

Indexed keywords

AMPHETAMINE; OXIDOPAMINE; RIBOSOME RNA; SILVER; TYROSINE 3 MONOOXYGENASE;

ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CIRCLING BEHAVIOR; DISEASE COURSE; DNA DAMAGE; DOPAMINERGIC NERVE CELL; HEMISPHERE; MALE; NERVE CELL; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; NUCLEOLUS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; STAINING; STEREOLOGY; STEREOMETRY; SUBSTANTIA NIGRA; SUBSTANTIA NIGRA PARS COMPACTA; VENTRAL TEGMENTUM;

ANIMALS; CELL NUCLEOLUS; CELLS, CULTURED; DOPAMINERGIC NEURONS; MALE; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; RATS; RATS, LONG-EVANS; SUBSTANTIA NIGRA;

EID: 84878897062     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.04.033     Document Type: Article

References (28)

1. Ahmad S., Park J., Radel J., Levant B. Reduced numbers of dopamine neurons in the substantia nigra pars compacta and ventral tegmental area of rats fed an n-3 polyunsaturated fatty acid-deficient diet: a stereological study. Neurosci. Lett. 2008, 438:303-307.
2. Bethel-Brown C.S., Zhang H., Fowler S.C., Chertoff M.E., Watson G.S., Stanford J.A. Within-session analysis of amphetamine-elicited rotation behavior reveals differences between young adult and middle-aged F344/BN rats with partial unilateral striatal dopamine depletion. Pharmacol. Biochem. Behav. 2010, 96:423-428.
3. Boulon S., Westman B.J., Hutten S., Boisvert F.M., Lamond A.I. The nucleolus under stress. Mol. Cell 2010, 40:216-227.
4. Carvalho G.A., Nikkhah G. Subthalamic nucleus lesions are neuroprotective against terminal 6-OHDA-induced striatal lesions and restore postural balancing reactions. Exp. Neurol. 2001, 171:405-417.
5. Cheng H.W., Tong J., McNeill T.H. Lesion-induced axon sprouting in the deafferented striatum of adult rat. Neurosci. Lett. 1998, 242:69-72.
6. Deumens R., Blokland A., Prickaerts J. Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp. Neurol. 2002, 175:303-317.
7. Eriksen N., Stark A.K., Pakkenberg B. Age and Parkinson's disease-related neuronal death in the substantia nigra pars compacta. J. Neural Transm. Suppl. 2009, 203-213.
8. Finkelstein D.I., Stanic D., Parish C.L., Tomas D., Dickson K., Horne M.K. Axonal sprouting following lesions of the rat substantia nigra. Neuroscience 2000, 97:99-112.
9. Glinka Y., Gassen M., Youdim M.B. Mechanism of 6-hydroxydopamine neurotoxicity. J. Neural Transm. Suppl. 1997, 50:55-66.
10. Gomide V., Bibancos T., Chadi G. Dopamine cell morphology and glial cell hypertrophy and process branching in the nigrostriatal system after striatal 6-OHDA analyzed by specific sterological tools. Int. J. Neurosci. 2005, 115:557-582.
11. Gundersen H.J., Jensen E.B., Kiêu K., Nielsen J. The efficiency of systematic sampling in stereology-reconsidered. J. Microsc. 1999, 193:199-211.
12. Healy-Stoffel M., Ahmad S.O., Stanford J.A., Levant B. A novel use of combined tyrosine hydroxylase and silver nucleolar staining to determine the effects of a unilateral intrastriatal 6-hydroxydopamine lesion in the substantia nigra: a stereological study. J. Neurosci. Methods 2012.
13. Hetman M., Pietrzak M. Emerging roles of the neuronal nucleolus. Trends Neurosci. 2012, 35:305-314.
14. Iacono D., O'Brien R., Resnick S.M., Zonderman A.B., Pletnikova O., Rudow G., An Y., West M.J., Crain B., Troncoso J.C. Neuronal hypertrophy in asymptomatic Alzheimer disease. J. Neuropathol. Exp. Neurol. 2008, 67:578-589.
15. Kirik D., Rosenblad C., Björklund A. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp. Neurol. 1998, 152:259-277.
16. Kong Q., Lin C.L. Oxidative damage to RNA: mechanisms, consequences, and diseases. Cell. Mol. Life Sci. 2010, 67:1817-1829.
17. Kostrzewa R.M., Jacobowitz D.M. Pharmacological actions of 6-hydroxydopamine. Pharmacol. Rev. 1974, 26:199-288.
18. Kuhn C.M., Schanberg S.M. Metabolism of amphetamine after acute and chronic administration to the rat. J. Pharmacol. Exp. Ther. 1978, 207:544-554.
19. Lee C.S., Sauer H., Bjorklund A. Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat. Neuroscience 1996, 72:641-653.
20. Mann D.M., Yates P.O. Pathogenesis of Parkinson's disease. Arch. Neurol. 1982, 39:545-549.
21. Marsden C.D. Parkinson's disease. Lancet 1990, 335:948-952.
22. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press, San Diego, California, USA. fourth ed.
23. Pietrzak M., Smith S.C., Geralds J.T., Hagg T., Gomes C., Hetman M. Nucleolar disruption and apoptosis are distinct neuronal responses to etoposide-induced DNA damage. J. Neurochem. 2011, 117:1033-1046.
24. Rieker C., Engblom D., Kreiner G., Domanskyi A., Schober A., Stotz S., Neumann M., Yuan X., Grummt I., Schütz G., Parlato R. Nucleolar disruption in dopaminergic neurons leads to oxidative damage and parkinsonism through repression of mammalian target of rapamycin signaling. J. Neurosci. 2011, 31:453-460.
25. Rudow G., O'Brien R., Savonenko A.V., Resnick S.M., Zonderman A.B., Pletnikova O., Marsh L., Dawson T.M., Crain B.J., West M.J., Troncoso J.C. Morphometry of the human substantia nigra in ageing and Parkinson's disease. Acta Neuropathol. 2008, 115:461-470.
26. Schmitz C., Hof P.R. Design-based stereology in neuroscience. Neuroscience 2005, 130:813-831.
27. Switzer R.C., Baun J., Tipton B., Segovia C., Ahmad S.O., Benkovic S.A. Modification of AgNOR staining to reveal the nucleolus in thick sections specified for stereological assessment of dopaminergic neurotoxicity in substantia nigra, pars compacta. Society for Neuroscience 2011 Abstract 2011.
28. Yuan X., Zhou Y., Casanova E., Chai M., Kiss E., Gröne H.J., Schütz G., Grummt I. Genetic inactivation of the transcription factor TIF-IA leads to nucleolar disruption, cell cycle arrest, and p53-mediated apoptosis. Mol. Cell 2005, 19:77-87.